Skip to main content

Table 3 Subgroup analysis of the efficacy of prophylactic transcatheter embolization in nonvariceal upper gastrointestinal bleeding; OR odds ratio

From: Prophylactic transcatheter arterial embolization for high-risk ulcers following endoscopic hemostasis: a meta-analysis

Clinical variable

Study number

Rebleed

Mortality

OR (95% CI)

P value

OR (95% CI)

P value

Hemoglobin (mean or median)

 < 8.0

3c,d,e

1.495 (0.694–3.219)

0.305

1.458 (0.545–3.897)

0.452

 ≥ 8.0

2a,b

3.642 (1.491–8.895)

0.005

8.77 (3.344–22.997)

< 0.001

Percentage of NSAID use (excluding aspirin)

 ≥ 20%

2c,d

2.83 (0.91–8.87)

0.074

8.0 (1.753–36.512)

0.007

 < 20%

2a,b

1.49 (0.69–3.22)

0.305

1.458 (0.545–3.897)

0.452

Follow-up

 30-day

3a,b,c

1.816 (0.896–3.683)

0.098

2.209 (0.94–5.192)

0.069

 NS

2d,e

3.394 (1.268–9.082)

0.015

8.981 (3.05–26.439)

< 0.001

  1. aMille 2015
  2. bLau 2018 [8]
  3. cLaursen 2014
  4. dKamiski 2017
  5. eKamiski 2019